Clozapine REMS Program: Indications & Important Selected Safety Information About Clozapine-Containing Products
This document was released on September 15, 2015 by the U.S. Food and Drug Administration as part of the new Clozapine Risk Evaluation and Mitigation Strategy (REMS) program. The document includes indications and important selected safety information about clozapine-containing products . . .
